Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kyowa Kirin Pharmaceutical Development Ltd

Clinical trials sponsored by Kyowa Kirin Pharmaceutical Development Ltd, explained in plain language.

Now part of Kyowa Kirin Co., Ltd. 4151 TOKYO

Pharmaceutical company developing treatments for rare diseases and oncology.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 2

Global XLH registry aims to map the disease's journey from childhood to adulthood

Knowledge-focused Recruiting now

This study is a worldwide registry that collects health information from people of all ages with X-Linked Hypophosphatemia (XLH), a rare genetic condition that affects bone growth and strength. Researchers will track how the disease progresses, what treatments patients receive, a…

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd • Aim: Knowledge-focused

Last updated Jul 11, 2026 00:00 UTC